Testing effectiveness (Phase 2)Study completedNCT00687271
What this trial is testing
MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)
Who this might be right for
Hypercholesterolemia
Merck Sharp & Dohme LLC 334